Solid Biosciences Inc.
SLDB· Nasdaq
Released May 15, 2025, after the close
10-Q filed May 15, 2025, 45 days after period end · 0000950170-25-072560
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$39.28M | -$24.30M | -$30.07M | -$25.33M |
| EPS Diluted | -$0.59 | -$0.64 | -$1.54 | -$3.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end
+7.0% from the close of May 15, 2025 to the close of May 16, 2025, the first after the release.